Loss-of- and gain-of-function mutations have been identified in ADAR1 and IFIH1 genes, respectively, in patients with AGS, in which the brain is one of the most affected organs accompanied by a type I IFN signature [37]. The gene discussed is IFIH1; the disease is Aicardi-Goutieres syndrome.